Teads CCO granted 1.4M shares; vesting corrected
Spilman Mary reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Spilman Mary reported acquisition or exercise transactions in this Form 4 filing.
Teads Holding Co. Chief Commercial Officer Mary Spilman reported an award of 1,400,000 shares of common stock. The shares were granted at a price of $0.00 per share, giving her direct ownership of 1,400,000 shares following the transaction. This amended filing clarifies a clerical error in the original report, changing the initial vesting date from December 5, 2025 to December 5, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,400,000 shares
Grant/Award
1 txn
Insider
Spilman Mary
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,400,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 1,400,000 shares (Direct)
Footnotes (1)
- F1. This Form 4 is being amended solely to report a clerical error in the vesting schedule disclosed in Footnote 1 of the original filing. The original filing incorrectly stated that the initial vesting date was December 5, 2025. The correct initial vesting date is December 5, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Teads (TEAD) report for Mary Spilman?
Teads reported that Chief Commercial Officer Mary Spilman received a grant of 1,400,000 shares of common stock. The shares were awarded at $0.00 per share as part of compensation, increasing her direct holdings to 1,400,000 shares after the transaction.
Is the Teads (TEAD) Form 4/A filing a new grant or an amendment?
The Form 4/A is an amendment to a prior filing, not a new grant. It was filed solely to correct a clerical error in the vesting schedule, updating the initial vesting date from December 5, 2025, to December 5, 2026.
What specific correction does the Teads (TEAD) Form 4/A make?
The amendment corrects the initial vesting date for the previously reported stock award. The original filing listed December 5, 2025, while the corrected initial vesting date disclosed in the amended Form 4/A is December 5, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.